State settles with Johnson & Johnson for selling drugs contaminated with metal

May 30, 2017

HELENA — Montana has joined with 42 other states who reached a $33 million settlement with Johnson & Johnson over selling drugs contaminated with metal.

Between 2009 and 2011 Johnson and Johnson announced voluntary recalls of medications including liquid Tylenol for infants and children, St. Joseph aspirin, Benadryl, Rolaids, Motrin and Zyrtec products.

The drugs were not manufactured, processed, packed or held in conformance with guidelines laid out in the federal Good Manufacturing Practices. In 2015 a subsidiary of Johnson and Johnson, McNeil Consumer Healthcare Division, admitted to selling adulterated medication and paid the U.S. Department of Justice a $25 million settlement.

Montana’s share of the settlement is $634,130.

“This settlement is a reminder to all companies operating in Montana that they must follow the rules if they are going to do business here,” said Attorney General Tim Fox. “Cutting corners is never acceptable, especially when doing so could adversely affect consumers’ health. This settlement is a victory for Montana consumers, and I’m glad my office helped take the lead on this case.”